Becton, Dickinson and Company (NYSE:BDX) Given New $275.00 Price Target at Raymond James
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) had its price target upped by stock analysts at Raymond James from $269.00 to $275.00 in a research note issued on Wednesday, Benzinga reports. The firm currently has an “outperform” rating on the medical instruments supplier’s stock. Raymond James’ price objective points to a potential upside […]
More Stories
Financial Analysis: WEX (NYSE:WEX) versus Sezzle (NASDAQ:SEZL)
WEX (NYSE:WEX – Get Free Report) and Sezzle (NASDAQ:SEZL – Get Free Report) are both business services companies, but which...
Insider Buying: Zymeworks Inc. (NYSE:ZYME) Director Purchases 11,958 Shares of Stock
Zymeworks Inc. (NYSE:ZYME – Get Free Report) Director Ecor1 Capital, Llc bought 11,958 shares of the business’s stock in a...
Enel SpA (OTCMKTS:ENLAY) Short Interest Up 296.5% in December
Enel SpA (OTCMKTS:ENLAY – Get Free Report) saw a large increase in short interest in the month of December. As...
Carlyle Secured Lending, Inc. 8.20% Notes due 2028 (NASDAQ:CGBDL) Short Interest Update
Carlyle Secured Lending, Inc. 8.20% Notes due 2028 (NASDAQ:CGBDL – Get Free Report) was the target of a large growth...
WisdomTree Emerging Markets Quality Dividend Growth Fund (NASDAQ:DGRE) Short Interest Down 57.0% in December
WisdomTree Emerging Markets Quality Dividend Growth Fund (NASDAQ:DGRE – Get Free Report) was the target of a significant drop in...
ProShares Nasdaq-100 High Income ETF (NASDAQ:IQQQ) Short Interest Down 55.0% in December
ProShares Nasdaq-100 High Income ETF (NASDAQ:IQQQ – Get Free Report) was the target of a significant decline in short interest...